[XENE] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
03-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -28.22%
YoY- -101.57%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 15 16 376 413 413 601 3,227 -97.22%
PBT -7,380 -7,517 -6,004 -7,714 -6,016 -3,263 -3,937 52.08%
Tax -513 -470 542 383 -350 -2,395 1,334 -
NP -7,380 -7,517 -6,004 -7,714 -6,016 -3,263 -3,937 52.08%
Tax Rate - - - - - - - -
Total Cost 7,395 7,533 6,380 8,127 6,429 3,864 7,164 2.14%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -49,200.00 -46,981.25 -1,596.81 -1,867.80 -1,456.66 -542.93 -122.00 5378.45%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.41 -0.42 -0.33 -0.51 -0.42 -0.23 -0.27 32.14%
EPS Diluted -0.41 -0.42 -0.33 -0.51 -0.42 -0.23 -0.27 32.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.